The tumor suppressor p53 is considered as the guardian of the genome which is activated following genotoxic stress. In many cell types, p53 mediates G1 cell cycle arrest as the predominant cellular response. Inactivation of wild-type p53 leads to loss of G1/S checkpoint control and to genomic instability, including increased spontaneous homologous recombination (HR). To determine whether regulation of the G1/S checkpoint is required for suppression of HR, we assessed recombination events using a plasmid substrate that stably integrated into the genome of p53-null mouse ®broblasts. Exogenous expression of a temperature-sensitive p53 protein (Ala135 to Val), which had lost trans-activation function and could not regulate G1/S transition when in mutant conformation, reduced HR rates to the same extent as wild-type p53. Furthermore, a p53 construct with an alternatively-spliced carboxy terminus also retained this ability in the absence of both activities, G1/S control and non-sequence speci®c DNA binding as mediated by the carboxy terminus. Our data dissociate regulation of HR by p53 from its role as a cell cycle checkpoint protein.
Introduction
The tumor suppressor gene p53 is viewed as the guardian of the genome (Lane, 1992) which regulates the cellular response to various stress signals, most notably exogenous DNA damage. In unstressed cells, p53 appears to be present at low levels and is assumed to exist in a latent form that requires modi®cation to become active (Giaccia and Kastan, 1998) . Activated p53 acts as a transcription factor that up-regulates several downstream genes. In many cell types, the dominant cellular response pathway is the G1 cell cycle arrest which is mediated by up-regulation of p21 (Kastan et al., 1992; El-Deiry et al., 1993) and which is assumed to allow for adequate repair of damaged DNA before entering S phase (Lane, 1992; Sherr, 1996) . In certain cell types and situations, p53 can alternatively trigger apoptosis (Ko and Prives, 1996; Sherr, 1996) . p53 has also been reported to be involved in control of the G2/M checkpoint and a variety of other aspects of cell proliferation and DNA metabolism (Ko and Prives, 1996; Levine, 1997; Janus et al., 1999a) . Suppression of spontaneous homologous recombination (HR) has recently been established as a new endpoint of wild-type p53 function (Meyn et al., 1994; Xia et al., 1994; WiesmuÈ ller et al., 1996; Bertrand et al., 1997; Mekeel et al., 1997; DuddenhoÈ er et al., 1998) . In a DNA repair pathway, recombinational processes may act to maintain genetic stability, but if deregulated or increased, genomic instability and malignant transformation can result. Importantly, increased HR could be a mechanism involved in loss of heterozygosity which is frequently observed in tumor development and progression (Cavenee et al., 1983; Koufos et al., 1984; EyfjoÈ rd et al., 1995) . Thus, suppression of spontaneous HR is a means by which p53 can maintain genome stability. The underlying mechanisms of how p53 is involved in regulation of HR in-vivo have not yet been identi®ed.
Control of the G1/S cell cycle checkpoint could be hypothesized as the main means by which p53 may indirectly suppress HR events. An increase in HR frequency following inactivation of wild-type p53 might accordingly be due to replication on DNA lesions leading to generation of recombinogenic structures or due to uncontrolled entry of cells already containing recombination intermediates into S phase, which may result in an increase of genetic exchanges. In the current study, we therefore addressed the following questions: (i) Is suppression of HR related to p53-dependent cell cycle checkpoint control? (ii) If p53 has a more direct function in regulation of HR, does the basic C-terminal domain constitute the responsible regulatory domain, considering that its biochemical properties appear closely related to recombination processes, i.e., binding to single-and double-stranded DNA, recognition of DNA mismatches, reannealing and strand transfer (Ko and Prives, 1996; Levine, 1997) ? Analogous to our previous work (Mekeel et al., 1997) , we assessed HR events occurring in a plasmid substrate which had been transfected into mouse ®broblasts. We found in-vivo evidence for a novel function of p53 in regulation of spontaneous HR that is distinct from its role as a cell cycle checkpoint protein. Furthermore, an intact C terminus was dispensable for suppression of HR to occur.
Results

Measurement of plasmid based homologous recombination events in rodent ®broblasts
To measure spontaneous HR in a chromosomal context, we constructed a plasmid substrate, designated pHWI, which carries two copies of the bacterial XGPRT gene each harboring either a 5' or a 3' prime deletion that inactivates gene function (Figure 1a) . Homologous recombination between these copies can reconstitute a functional gene conferring resistance to XHATM selection in a colony assay (Figure 1b) . We ®rst transfected pHWI into immortalized p53-null mouse embryo ®broblasts (MEF), designated 10.1 (Harvey and . This cell line displayed a mean HR rate of about 40610 74 per cell generation (Table 1a ). In the corresponding primary MEF line which had endogenous wild-type p53, HR rates were lower by more than one order of magnitude, i.e., about 1610
74
, consistent with the results for primary rat embryo ®broblasts (REF) (Table 1a ) and our previously published data (Mekeel et al., 1997) . Although during immortalization p53 mutation is not the only genetic event that occurs, p53 status is considered the major determinant of HR during tissue culture passage of mouse ®broblasts as HR rates in primary and subsequently immortalized MEF that had both p53 alleles genetically knocked out were virtually identically elevated (data not shown).
G1/S checkpoint control is lost by mutation at codon 135 or inactivation of the C-terminal domain
We set out to investigate to which extent G1/S cell cycle checkpoint control and non-speci®c DNA binding activity as mediated by the basic C-terminal domain of p53 in¯uenced suppression of HR. We employed two cell pairs which exogenously expressed two variants of a murine p53 mutant: (i) 10.1/Val5 cells expressed p53 with an Ala135 to Val mutation which mediates a temperature-sensitive phenotype with the protein conformation being wild-type at 4328C or mutant at 5378C (Ginsberg et al., 1991; Martinez et al., 1997; Notterman et al., 1998) . (ii) 10.1/VAS5 cells expressed the same mutant, but with the last 26 amino acids (normally-spliced form) exchanged with 17 dierent residues (alternatively-spliced, Val135AS) leading to loss of non-speci®c DNA binding activity (Kulesz-Martin et al., 1994; Bayle et al., 1995) . Considering suggestions that at 378C p53-Val135 could display features of both, mutant and wild-type conformation, at least in rat ®broblast lines (Martinez et al., 1991; Stewart et al., 1995) , we sought to con®rm the absence of damage-inducible p53 activation at this temperature.
There was no increase of p53-Val135 protein levels and no p21 induction after exposure to ionizing radiation at 378C (Figure 2 ). The alternatively-spliced p53 variant was found to be mainly sequestered in the nucleus, independent of conformation and consistent with a previous report (Kulesz-Martin et al., 1994) . Defective p21-dependent damage response was con®rmed by the absence of transcriptional activation of the p21 promoter ( Figure 3 ) and by the lack of G1 cell cycle arrest (Figure 4a , 378C column). Absent G1 arrest was best seen 9 h following irradiation and was judged based on a maintained level of S phase fraction coupled with a decrease in G1 population since entry into G1 was limited by radiation induced G2/M block. For comparison, the same picture was observed after irradiation of immortalized MEF which had harbored a spontaneous p53 mutation as assessed functionally by loss of p53-dependent DNA damage response ( Figure  4b ). Together, these data veri®ed that p53-Val135 and p53-Val135AS had lost the ability for sequence-speci®c DNA binding and transcriptional activation of the p21 pathway at the restrictive temperature of 378C.
In the control experiments at 328C, normally-spliced p53 in wild-type conformation had translocated into the nucleus, which was accompanied by strong induction of p21 protein levels ( Figure 2 ). No further p53 or p21 protein induction could be detected after irradiation. These ®ndings are consistent with previous reports (Ginsberg et al., 1991; Isaacs et al., 1997; Martinez et al., 1997) . Despite lack of visible p21 induction, irradiation did mediate a clear G1 arrest after 9 h, represented by an unchanged high portion of cells in G1 and a decreasing number of S phase cells ( Figure 4a ). This cell cycle response was virtually identical to the G1 block seen in primary ®broblasts with endogenous wild-type p53 (Figure 4b ). Therefore, the p21-dependent cell cycle checkpoint pathway is intact in the 10.1 cells and can be activated by expression of wild-type p53. Although alteration of the C terminus was reported to activate the central core domain of p53 for sequence-speci®c DNA binding, in our experimental setting alternativelyspliced p53 in wild-type conformation appeared not to be transcriptionally activated at 328C with absence of p21 induction and G1/S control (Figures 2 ± 4) (see Discussion).
G1/S checkpoint control and the basic C-terminal domain are not essential for suppression of homologous recombination
Despite loss of trans-activation function at 378C, p53-Val135 still mediated a statistically highly signi®cant reduction of HR compared to parental 10.1 cells, i.e., a 14-fold suppression to a mean HR rate of 2.8610 74 (P=0.004; Table 1b ). This suppression was of the same magnitude of eect as mediated by endogenous wildtype p53 (1.3610 74 ). Of note, both cell lines, 10.1 and 10.1/Val5, lacked not only the ability to regulate the G1/S checkpoint but also exhibited virtually identical growth characteristics in cell culture independent of applied G418 selection pressure, including a population doubling time of 16 h and plating eciencies of around 30%.
We next asked whether regulation of HR involved the basic C-terminal domain of p53 which biochemical properties implied potential interactions with recombination intermediates. In addition, as the alternatively- Figure 2 Study of p53-dependent DNA damage response by Western blot analysis of p53 and p21 levels without irradiation (0) and after exposure to 8 Gy ionizing radiation (IR), shown here for the 6-h time point. 10.1/Val5 cells expressed the temperaturesensitive p53-Val135 protein with an intact C-terminus (NS, normally-spliced) which assumed a mutant or a wild-type conformation at 378C or 328C, respectively. By analogy, 10.1/ VAS5 cells expressed the same mutant, but with an alternativelyspliced C-terminal domain (AS). p53 levels were determined in cellular (C) and in nuclear lysates (N), and p21 levels in whole-cell lysates Figure 2 were tested. CAT activities were determined after 48 h, normalized to an internal b-galactosidase control and are presented relative to the activity in 10.1 cells (p53-null, vector alone). Bars represent the means+s.e. NS, normallyspliced p53 variant; AS, alternatively-spliced spliced variants also lacked the ability to control G1/S transition these experiments were expected to further corroborate the functional separation of G1/S checkpoint control and regulation of HR. When 10.1/VAS5 cells were maintained at 378C, thus expressing the mutant p53-Val135AS product, again a suppressed HR rate of 2.1610 74 was found which represented a 19-fold reduction compared to 10.1 cells (P=0.006; Table  1b ). When switched to wild-type conformation the same suppression was seen (P=0.016). Colony assays could not be performed on 10.1/Val5 cells at 328C because these cells ceased to proliferate at this temperature within a few days.
The human p53-Ala143 mutant partially suppresses homologous recombination
In order to obtain independent con®rmation that mutant p53 such as present in 10.1/Val5 cells can suppress HR, we chose to employ the human p53-Ala143 mutant: The Ala143 mutation corresponds to codon 137 in mouse and, like the murine Val135 (p53-Val135 with alternatively-spliced C terminus, AS) were evaluated at 378C and 328C incubation temperature. The response to IR (8 Gy) after 9 h is shown, except for alternatively-spliced p53 at 328C where lack of damage-induced G1 arrest was best visible at the 6-h time point. (b) For comparison, cell cycle pro®les of immortalized MEF harboring a spontaneous p53 mutation and of primary rat ®broblasts with endogenous wild-type p53 are displayed mutation, mediates a temperature-sensitive phenotype (Zhang et al., 1994) . Therefore, we hypothesized that p53-Ala143 should be functional with regard to regulation of HR. Analogous to the previous experiments, p53-Ala143 was exogenously expressed in 10.1 cells and after transfection of pHWI a fourfold reduction of HR rates was observed (Table 1c) . Although this suppression was found to be statistically signi®cant at P=0.041, it appeared to be only partial when compared to the eects of wild-type p53. We sought to obtain additional con®rmation of these data by performing a series of subsequent experiments in which the sequence of transfections was reversed: pHWI was ®rst integrated into 10.1 cells and singleclone derived populations were subsequently transfected with the p53-Ala143 expression vector or a control vector (data not shown). A virtually identical suppression of HR was obtained (mean, fourfold; range, 2-to 11-fold).
Discussion
Suppression of homologous recombination is independent of G1/S control
In many cell types, p53 is considered to prevent genetic instability via its function as a G1/S cell cycle checkpoint guardian. However, here we report in-vivo evidence for a function of p53 in suppressing spontaneous HR that is distinct from its role in the G1/S checkpoint. This ®nding was based on the observation that several p53 mutants and variants which all lacked the ability to mediate G1 arrest, i.e., the murine temperature-sensitive p53-Val135 in mutant conformation, the human p53-Ala143 mutant, and the alternatively-spliced p53-Val135 proteins in mutant and in wild-type conformation, were still capable of suppressing HR in a transfected plasmid substrate.
When comparing the suppression by mutant p53-Val135 (14-fold) to the eects of wild-type p53 (28-fold), the reduction appeared to be somewhat less though not statistically signi®cantly. If this were a true dierence, it could be due to a contribution of the G1/ S checkpoint to suppression of HR or due to a partial disruption of the p53 domain responsible for regulation of HR by the mutation at codon 135. Analysis of p53-Ala143 revealed a statistically signi®cant reduction of HR rates by fourfold which provided independent con®rmation that a mutant such as p53-Val135 can in principle remain capable of suppressing HR. The data also demonstrate that suppression can be only partial when compared with the dierence between p53-null MEF and cells with wild-type p53. Previously, the p53-Ala143 mutant led to increased HR rates when employed to abrogate wild-type p53 function in a dominant-negative fashion (Meyn et al., 1994; Mekeel et al., 1997) . However, these data still allow for the possibility that HR rates would have been higher in the absence of any p53 protein. Furthermore, the results are dicult to interpret, since either cells were used in which wild-type p53 was already inactivated by the SV40 large T Antigen (Meyn et al., 1994) or the cell pair under comparison diered genetically in more than just p53 status (Pardo et al., 1994; Mekeel et al., 1997) . Of note, our observation that alternativelyspliced wild-type p53 failed to activate the p21-dependent pathway is consistent with a recent report by Schwartz et al. (1997) who did not see G1 arrest in mouse L12 cells transfected with this p53 variant either, but appears to be inconsistent with other studies which reported activation of the central core domain for sequence-speci®c DNA binding following alteration of the C terminus (Hupp and Lane, 1994; Bayle et al., 1995; Wu et al., 1995) . Potentially, the somewhat reduced protein levels in 10.1/VAS5 cells (Figure 2 ) could have compromized detection of trans-activation activity in our studies. Alternatively, we suggest that the results of determining the activation of sequencespeci®c DNA binding by the C terminus in in-vitro assays may not necessarily be transferable to experiments that assess p53's trans-activation function invivo, and may as well be cell-type dependent.
How does p53 regulate homologous recombination?
Previous studies on p53 and HR were based on various means of wild-type p53 inactivation, i.e., by SV40 large T antigen, by HPV-E6, by a dominant-negative mutant or by allelic deletion, which led not only to loss of trans-activation function, but also to disruption of the presumptive downstream pathway or regulatory protein domain responsible for suppression of HR (Meyn et al., 1994; Xia et al., 1994; WiesmuÈ ller et al., 1996; Bertrand et al., 1997; Mekeel et al, 1997) . Mechanistic insight has come from WiesmuÈ ller and colleagues who studied changes in HR frequencies as a result of altered recombination substrates (DuddenhoÈ er et al., 1998). p53 was found to display a distinct anity to mismatches included in the DNA substrate and bound to synthetic three-stranded DNA substrates mimicking early recombination intermediates. Consistent with these data, p53 was recently observed to bind speci®cally to Holliday junctions (Lee et al., 1997) . Therefore, one way of directly regulating HR could involve a mismatch repair activity of p53 (DuddenhoÈ er et al., 1998) which may be related to its recently demonstrated 3' to 5' exonuclease activity (Mummenbrauer et al., 1996; Janus et al., 1999b) and which would parallel the described anti-recombinogenic properties of the MutSHL mismatch repair system (Fishel and Kolodner, 1995) .
Another potential regulatory mechanism could involve trans-activation of yet unidenti®ed downstream genes by p53. Although we cannot exclude, nor prove directly, the possible existence of a subnuclear p53-Val135 fraction which remains in wild-type conformation at 378C and constitutively activates such target genes, we consider this unlikely in view of the complete absence of downstream transactivation by the p53-Val135 mutants in the cell populations under study (Figures 2 ± 4) . Hirano et al. (1995) also observed loss of binding to the p53 consensus binding sequence by human p53-Val138. Other data clearly support the idea that mutant p53-Val135 can retain trans-activation independent regulatory properties (Guillouf et al., 1995; Mummenbrauer et al., 1996; Tang et al., 1999) .
Recombination intermediates could provide the trigger for apoptosis. However, this appears very dicult to study directly. Radiation-induced DNA damage may resemble DNA ends that are present during recombinational exchanges. However, we and others have not found p53-dependent apoptosis after irradiation to play a role in non-transformed MEF (Sands et al., 1995; Mekeel et al., 1997) . Furthermore, apoptosis was unlikely to account for recombination dierences seen between 10.1 and 10.1/Val5 cells (Table  1) , since growth characteristics, transfection frequencies and plating eciencies for these cell lines have not revealed signi®cant dierences (data not shown).
Which is the p53 domain responsible for regulation of HR? We found that non-speci®c DNA binding activity as mediated by the basic C-terminal domain of p53 was not essential for suppression of HR to occur. The N-terminus might play a role through the binding site with RPA which has functions in DNA repair and recombination (Wold et al., 1997; Leitner et al., 1996) . However, other available data hint towards the central core region of p53 as being responsible for regulation of HR. StuÈ rzbecher et al. (1996) mapped the interaction with the Rad51 recombinase, a central homologous pairing and strand exchange protein, to central regions of the p53 protein. The central core domain was found to contain p53's intrinsic exonuclease activity (Mummenbrauer et al., 1996; Janus et al., 1999b) and also binds non-speci®cally to internal regions of single-stranded DNA (Bakalkin et al., 1994) . Apparently, the conformational change induced by the amino acid exchange Alanin to Valin at position 135 was not sucient to disrupt the presumptive regulatory domain in our study. However, mutational analysis of the core region will be dicult to perform since amino acid exchanges at one location could easily aect other neighboring domains in the context of p53's tertiary structure.
A direct role of p53 in maintenance of genomic stability?
Accumulating evidence attributes direct regulatory functions in DNA metabolism to p53. The data presented here imply that p53 can maintain genome integrity by suppression of spontaneous HR independently of the G1/S checkpoint and probably also in the absence of transcriptional activation. Furthermore, p53 has been suggested to act in a post-replicative mismatch repair pathway (Mummenbrauer et al., 1996; Huang, 1998) , it co-localizes with DNA synthesis and the DNA replication apparatus (Huang, 1998) , interacts with viral replication (Deppert, 1994) , migrates into the nucleus with S phase (Shaulsky et al., 1990; Martinez et al., 1991) , and interacts with a variety of proteins involved in DNA repair (for further review, see Janus et al., 1999a) . Deppert and colleagues (Janus et al., 1999b) recently made the intriguing observation that p53's exonuclease and sequencespeci®c DNA binding activities appeared to be mutually exclusive functions. This has led the authors to formulate a dual p53 model which may signi®cantly extend p53's role as a guardian of the genome (Janus et al., 1999a) , and which is supported by our data: In addition to the well documented cellular stress responses mediated by activated p53, the model postulates regulatory functions in DNA metabolism such as repair of endogenous DNA damage, control of replication and recombination when p53 is in its latent' state which is generally considered inactive for transcriptional regulation. To test this hypothesis more directly, it will be necessary to de®ne this latent protein form in more detail, for example by transfecting a combination of trans-activation and phosphorylation defective candidate mutants into a p53-null cellular background, and by subsequent study of recombinational endpoints in vitro and in vivo.
Material and methods
Cell lines
MEF and REF were grown as described (Powell et al., 1995; Mekeel et al., 1997) . Primary ®broblast cultures were initiated at passage 3 from 12 ± 14 day old Balb/c mouse embryos or at passages 5 ± 10 from 7 ± 14 day old Sprague-Dawley rat embryos (Charles River Breeding Laboratories, Massachusetts General Hospital). Cell line 10.1 is an established Balb/c 3T3 line that has lost both p53 alleles during immortalization (Harvey and , and in the MEF-A3 line the p53 alleles had been genetically knocked-out (Jacks et al., 1994) . p53-Ala143 was added back into 10.1 cells by transfection of linearized pC53-SCX3 via the calcium phosphate coprecipitation method. The parental vector, pCMV-neo, was used in control experiments. Transfected clones were selected with 500 mg/ml G418 sulfate (active drug concentration, Mediatech). The lines 10.1/Val5 and 10.1/VAS5k1 had been established previously .
Plasmid construction
Plasmid construction was carried out using standard procedures. An EcoRI linker was inserted into the ClaI site of pBABEpuro (Morgenstern and Land, 1990) , the puromycin resistance gene under the control of an early SV40 promoter was taken out as an EcoRI fragment and inserted into pD2 which contains a copy of the XGPRT gene inactivated by a 5' prime deletion mutation of 460 bp (Hamilton and Thacker, 1987) . Another XGPRT copy was constructed by amplifying a 930-bp fragment from pSV2gpt (Mulligan and Berg, 1980 ) via a standard PCR approach. Primers 5'-CGC GGG ATC CCA GCT GTG GAA TGT G-3' and 5'-CGC GGG ATC CAT CAA CAA CAT AGT C-3' annealed to the PvuII site at the beginning of the SV40 promoter and to the EcoRV site within the XGPRT gene, respectively (new BamHI sites are underlined). The generated BamHI fragment which had lost the EcoRV site contained an inactive gene copy that lacked the 3' end of the gene (475 bp). This 3' deletion gene copy was subcloned into the unique BamHI site of pD2puro generating plasmids pHWD and pHWI. These plasmids contain the two XGPRT gene copies either in direct or inverted tandem repeat. The plasmids are 6.8 kb in size, can be linearized by PvuI and undergo bacterial ampli®cation as a low-copy number plasmid in the presence of ampicillin at 140 mg/ml.
Recombination assays
Primary MEF and REF were transfected with pHWI between passages 8 and 15. 10.1/VAS5 cells were switched to 328C 24 h prior to transfection. Transfection of pHWI was carried out using the calcium phosphate co-precipitation method (Mekeel et al., 1997) . Stable chromosomal integration of pHWI was selected for by puromycin at 2.5 mg/ml (Sigma). Antibiotic resistant colonies occurred within 12 ± 18 days of selection with fresh media added every 5 days. Parallel cultures were ampli®ed and reseeded at 100 ± 500 cells per 25 cm 2 to determine plating eciencies and at de®ned densities between 10 6 and 10 3 cells per 75 cm 2 to determine HR frequencies. After addition of XHATM (xanthine, hypoxanthine, aminopterin, thymidine, and mycophenolic Regulation of homologous recombination by p53 H Willers et al acid at 10, 13.6, 0.17, 3.87, and 10 mg/ml, respectively; all Sigma) to the 75 cm 2¯a sks, colony development was allowed over 14 ± 18 days if there was no wild-type p53 status and over 21 ± 28 days for slow growing cell lines with wild-type p53. Flasks at the appropriate densities yielding about 20 ± 200 colonies were stained, all colonies containing at least 50 cells were counted and the HR frequency was recorded (resistant colonies/cells seeded6plating eciency). HR rates were determined as described previously (Mekeel et al., 1997) . Data sets where signi®cantly elevated HR frequencies were attributed to transfection-linked recombination events were not included in the analysis. Statistical evaluations were performed assuming log normal distributions.
Western blotting
To assess p53 protein stabilization and p21 induction, DNA damage was induced by irradiation with 8 Gy (280 kVp Xray tube, Siemens). 10.1/Val5 and 10.1/VAS5 cell lines were switched to 328C 24 h prior to irradiation. Cells were in exponential growth phase at 70 ± 80% con¯uence at time of irradiation. Isolation of whole-cell and nuclear lysates and Western blotting was carried out as described (Mekeel et al., 1997; Kachnic et al., 1999) .
Transactivation analysis
p53 trans-activation activity was assessed using a modi®ed CAT Fluor diusion assay (Neumann et al., 1987) . Approximately 2610 5 cells/21 cm 2 were transfected via the calcium phosphate co-precipitation method with 7.5 mg pWWP-CAT (El-Deiry et al., 1993) and 1.9 mg pSV-bgalactosidase (Promega). Cells were incubated at 378C for 48 h or switched immediately to 328C. Cell lysates were obtained utilizing reporter lysis buer (Promega). Six to 29% of the lysates were incubated with 1 mM chloramphenicol (Sigma) and 0.025 mmol 14 C-Butyryl-CoA (0.1 mCi; NENDuPont) after addition of 5 ml of Econo¯uor (NEN-DuPont) for 1 h at 378C. Immediately following incubation, activities were measured in a Liquid Scintillation Counter (Packard LVP164000 Series) and normalized to the b-galactosidase control. b-galactosidase assays were carried out essentially as described by the manufacturer (Promega). All experiments were performed in triplicate with one to three determinations per experiment.
Flowcytometric analysis
To investigate p53-dependent G1/S transition, cell cycle pro®les in response to X-rays were measured usinḡ owcytometric analysis. Twenty-four hours prior to irradiation 10.1/Val5 and 10.1/VAS5 cells were subjected to temperature shift to 328C. Approximately 10 6 cells/175 cm 2 were in exponential asynchronous growth at the time of irradiation with 8 Gy. Cell cycle distributions were assessed 0, 3, 6, 9, 12, and 24 h after irradiation using an ethanol ®xation and propidium iodide staining method essentially as described (Powell et al., 1995; Mekeel et al., 1997) .
